Cargando…
Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series
The coronavirus disease 2019 (COVID-19) pandemic remains one of the largest global health crises of the last century. Fortunately, COVID-19 vaccines have proven to be one of the most promising options in halting the progression of the pandemic. As more and more people receive COVID-19 vaccines, the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400017/ https://www.ncbi.nlm.nih.gov/pubmed/37546104 http://dx.doi.org/10.7759/cureus.41371 |
_version_ | 1785084374378610688 |
---|---|
author | Bekal, Sundeep Husari, George Okura, Marcel Huang, Charity A Bukari, Mohammed S |
author_facet | Bekal, Sundeep Husari, George Okura, Marcel Huang, Charity A Bukari, Mohammed S |
author_sort | Bekal, Sundeep |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) pandemic remains one of the largest global health crises of the last century. Fortunately, COVID-19 vaccines have proven to be one of the most promising options in halting the progression of the pandemic. As more and more people receive COVID-19 vaccines, the medical community has learned a great deal about their efficacy and the occurrence of very rare adverse effects. While the number of thromboembolic events post-adenoviral vaccines has been well-documented in the medical literature, there has been limited information regarding thrombosis development after receiving a messenger RNA (mRNA)-based vaccine. This case series highlights four different patients who received an mRNA-based COVID-19 vaccine and subsequently developed venous thromboembolism. Therefore, we hope that after reviewing this article, physicians will be more aware of thrombosis-related developments following mRNA vaccine administration for COVID-19. Fortunately, with early diagnosis and prompt treatment, patients can still expect full recovery from any vaccine thrombosis-associated complications, and the benefits of receiving an mRNA-based COVID-19 vaccine still outweigh the risks of post-vaccination complications. |
format | Online Article Text |
id | pubmed-10400017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-104000172023-08-04 Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series Bekal, Sundeep Husari, George Okura, Marcel Huang, Charity A Bukari, Mohammed S Cureus Infectious Disease The coronavirus disease 2019 (COVID-19) pandemic remains one of the largest global health crises of the last century. Fortunately, COVID-19 vaccines have proven to be one of the most promising options in halting the progression of the pandemic. As more and more people receive COVID-19 vaccines, the medical community has learned a great deal about their efficacy and the occurrence of very rare adverse effects. While the number of thromboembolic events post-adenoviral vaccines has been well-documented in the medical literature, there has been limited information regarding thrombosis development after receiving a messenger RNA (mRNA)-based vaccine. This case series highlights four different patients who received an mRNA-based COVID-19 vaccine and subsequently developed venous thromboembolism. Therefore, we hope that after reviewing this article, physicians will be more aware of thrombosis-related developments following mRNA vaccine administration for COVID-19. Fortunately, with early diagnosis and prompt treatment, patients can still expect full recovery from any vaccine thrombosis-associated complications, and the benefits of receiving an mRNA-based COVID-19 vaccine still outweigh the risks of post-vaccination complications. Cureus 2023-07-04 /pmc/articles/PMC10400017/ /pubmed/37546104 http://dx.doi.org/10.7759/cureus.41371 Text en Copyright © 2023, Bekal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Infectious Disease Bekal, Sundeep Husari, George Okura, Marcel Huang, Charity A Bukari, Mohammed S Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series |
title | Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series |
title_full | Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series |
title_fullStr | Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series |
title_full_unstemmed | Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series |
title_short | Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series |
title_sort | thrombosis development after mrna covid-19 vaccine administration: a case series |
topic | Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400017/ https://www.ncbi.nlm.nih.gov/pubmed/37546104 http://dx.doi.org/10.7759/cureus.41371 |
work_keys_str_mv | AT bekalsundeep thrombosisdevelopmentaftermrnacovid19vaccineadministrationacaseseries AT husarigeorge thrombosisdevelopmentaftermrnacovid19vaccineadministrationacaseseries AT okuramarcel thrombosisdevelopmentaftermrnacovid19vaccineadministrationacaseseries AT huangcharitya thrombosisdevelopmentaftermrnacovid19vaccineadministrationacaseseries AT bukarimohammeds thrombosisdevelopmentaftermrnacovid19vaccineadministrationacaseseries |